| Article title | Author | Date |
|---|---|---|
| Study reveals surgical consequences of severe obesity | Labseeker | 2015-06-11 |
| Merck teams up with llumina and Genea | Labseeker | 2015-06-11 |
| FDA issues clearance for Angion Begin | Labseeker | 2015-06-11 |
| New progress doubles the survival time of Cancel | Labseeker | 2015-06-11 |
| VaxInnate begins phase II trial | Labseeker | 2015-06-05 |
| Cancer screening increase may reflect Affordable Care Act | Labseeker | 2015-06-05 |
| First phase of Amway's new Site | Labseeker | 2015-06-05 |
| Study maps types of physical activity associated with better | Labseeker | 2015-06-05 |
| WHO accepts Elafibranor as generic name | Labseeker | 2015-06-05 |
| Elusys Therapeutics gets FDA acceptance for BLA of Anthim | Labseeker | 2015-06-03 |
© 2006-2015 Labseeker. All Rights Reserved.